Metabolic alterations mediated by STAT3 promotes drug persistence in CML
Open accessThe DOI matches its Crossref record; 75 of the 77 references it cites were found in a registry or an index.
Abstract
Leukemic stem cells (LSCs) can acquire non-mutational resistance following drug treatment leading to therapeutic failure and relapse. However, oncogene-independent mechanisms of drug persistence in LSCs are incompletely understood, which is the primary focus of this study. We integrated proteomics, transcriptomics, and metabolomics to determine the contribution of STAT3 in promoting metabolic changes in tyrosine kinase inhibitor (TKI) persistent chronic myeloid leukemia (CML) cells. Proteomic and transcriptional differences in TKI persistent CML cells revealed BCR-ABL-independent STAT3 activation in these cells. While knockout of STAT3 inhibited the CML cells from developing drug-persistence, inhibition of STAT3 using a small molecule inhibitor sensitized the persistent CML cells to TKI treatment. Interestingly, given the role of phosphorylated STAT3 as a transcription factor, it localized uniquely to genes regulating metabolic pathways in the TKI-persistent CML stem and progenitor cells. Subsequently, we observed that STAT3 dysregulated mitochondrial metabolism forcing the TKI-persistent CML cells to depend on glycolysis, unlike TKI-sensitive CML cells, which are more reliant on oxidative phosphorylation. Finally, targeting pyruvate kinase M2, a rate-limiting glycolytic enzyme, specifically eradicated the TKI-persistent CML cells. By exploring the role of STAT3 in altering metabolism, we provide critical insight into identifying potential therapeutic targets for eliminating TKI-persistent LSCs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Trimmomatic: a flexible trimmer for Illumina sequence data
Bolger, A. M., Lohse, M., & Usadel, B. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btu170 · Cited by 65,548
The Sequence Alignment/Map format and SAMtools
Li, H., Handsaker, B., Wysoker, A., Fennell, T., Ruan, J., Homer, N., Marth, G., Abecasis, G., Durbin, R., & 1000 Genome Project Data Processing Subgroup (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp352 · Cited by 62,041
Fast and accurate short read alignment with Burrows-Wheeler transform
Li, H., & Durbin, R. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp324 · Cited by 58,607
Szklarczyk, D., Gable, A. L., Lyon, D., Junge, A., Wyder, S., Huerta-Cepas, J., Simonovic, M., Doncheva, N. T., Morris, J. H., Bork, P., et al. (2019) · Nucleic Acids Research · doi:10.1093/nar/gky1131 · Cited by 17,749
Heinz, S., Benner, C., Spann, N., Bertolino, E., Lin, Y. C., Laslo, P., Cheng, J. X., Murre, C., Singh, H., & Glass, C. K. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.05.004 · Cited by 13,382
Tumour heterogeneity and resistance to cancer therapies
Dagogo-Jack, I., & Shaw, A. T. (2018) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2017.166 · Cited by 3,846
deepTools: a flexible platform for exploring deep-sequencing data
Ramírez, F., Dündar, F., Diehl, S., Grüning, B. A., & Manke, T. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku365 · Cited by 3,738
MetaboAnalyst 4.0: towards more transparent and integrative metabolomics analysis
Chong, J., Soufan, O., Li, C., Caraus, I., Li, S., Bourque, G., Wishart, D. S., & Xia, J. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky310 · Cited by 3,629
The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth
Christofk, H. R., Vander Heiden, M. G., Harris, M. H., Ramanathan, A., Gerszten, R. E., Wei, R., Fleming, M. D., Schreiber, S. L., & Cantley, L. C. (2008) · Nature · doi:10.1038/nature06734 · Cited by 2,820
Reductive glutamine metabolism by IDH1 mediates lipogenesis under hypoxia
Metallo, C. M., Gameiro, P. A., Bell, E. L., Mattaini, K. R., Yang, J., Hiller, K., Jewell, C. M., Johnson, Z. R., Irvine, D. J., Guarente, L., et al. (2012) · Nature · doi:10.1038/nature10602 · Cited by 1,791
Cited by
Mitochondrial STAT3 exacerbates LPS-induced sepsis by driving CPT1a-mediated fatty acid oxidation
Li, R., Li, X., Zhao, J., Meng, F., Yao, C., Bao, E., Sun, N., Chen, X., Cheng, W., Hua, H., et al. (2022) · Theranostics · doi:10.7150/thno.63751 · Cited by 158
Metabolomics in drug research and development: The recent advances in technologies and applications
Pang, H., & Hu, Z. (2023) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2023.05.021 · Cited by 97
Deregulated transcription factors in cancer cell metabolisms and reprogramming
Kant, R., Manne, R., Anas, M., Penugurti, V., Chen, T., Pan, B., Hsu, C.-C., & Lin, H. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.10.001 · Cited by 80
Deregulated transcription factors in the emerging cancer hallmarks
Hasan, A., Khan, N. A., Shahab Uddin, M. S., Khan, A. Q., & Steinhoff, M. S. (2023) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2023.12.001 · Cited by 48
Metabolic adaptation to tyrosine kinase inhibition in leukemia stem cells
Qiu, S., Sheth, V., Yan, C., Liu, J., Chacko, B. K., Li, H., Crossman, D. K., Fortmann, S. D., Aryal, S., Rennhack, A., et al. (2023) · Blood · doi:10.1182/blood.2022018196 · Cited by 45
Self-citation
Metadata
- Authors
- Patel, S. B., Nemkov, T., Stefanoni, D., Benavides, G. A., Bassal, M. A., Crown, B. L., Matkins, V. R., Camacho, V., Kuznetsova, V., Hoang, A. T., Tenen, D. E., Wolock, S. L., Park, J., Ying, L., Yue, Z., Chen, J. Y., Yang, H., Tenen, D. G., Ferrell, P. B., Lu, R., Darley-Usmar, V., D’Alessandro, A., Bhatia, R., & Welner, R. S.
- Affiliations
- University of Alabama at Birmingham (US)
- University of Colorado Anschutz (US)
- Harvard University (US)
- Beth Israel Deaconess Medical Center (US)
- Dicerna Pharmaceuticals (United States) (US)
- National University of Singapore (SG)
- Vanderbilt University Medical Center (US)
- Corresponding author
- Welner, Robert S.
- ORCID
- Patel, Sweta B.
- Nemkov, Travis
- Stefanoni, Davide
- Benavides, Gloria A.
- Bassal, Mahmoud A.
- Crown, Brittany L.
- Camacho, Virginia
- Kuznetsova, Valeriya
- Wolock, Samuel L.
- Park, Jihye
- Yue, Zongliang
- Chen, Jake Y.
- Yang, Henry
- Tenen, Daniel G.
- Ferrell, Paul Brent
- Lu, Rui
- Darley-Usmar, Victor
- D’Alessandro, Angelo
- Bhatia, Ravi
- Welner, Robert S.
- Venue
- Leukemia
- Published
- 2021-06-12
- Volume
- 35
- Issue
- 12
- Pages
- 3371-3382
- ISSN
- 0887-6924 (ISSN-L)
- 1476-5551
- PMC
- PMC8632690
- OpenAlex
- W3171658473
- Cited by
- 56
- References
- 77
- Citations by year
- 2026: 11 · 2025: 10 · 2024: 13 · 2023: 11 · 2022: 8 · 2021: 3
- FWCI
- 6.04
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Leukemia (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- National University of Singapore (submittedVersion, cc-by)
- Funders
- American Society of Hematology
- University of Alabama at Birmingham (P30-AI-027767, P30CA013148)
- University of Alabama (P30 CA013148, P30 AI027767)
- National Institutes of Health (P30-AI- 027767, P30-CA- 013148, CA013148, AI027767)
- Center for AIDS Research, University of Washington (CA013148, P30 AI027767, AI027767)
- National Heart, Lung, and Blood Institute (K23HL138291, P01HL131477)
- National Cancer Institute (R01CA095684, CA013148, R35CA197697, R01CA248794, P30CA013148)
- National Institute of Allergy and Infectious Diseases (P30AI027767)
- Topics
- Health Sciences › Medicine › Hematology › Chronic Myeloid Leukemia Treatments
- Health Sciences › Medicine › Hematology › Acute Myeloid Leukemia Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Tyrosine Phosphatases
- Keywords
- STAT3, chronic myeloid leukemia, drug resistance, leukemia stem cells, tyrosine kinase inhibitors, mitochondrial metabolism, glycolysis, oxidative phosphorylation, PKM2, metabolic reprogramming, STAT3 inhibitor, relapse
- MeSH terms
- Animals, Female, Glycolysis, Male, Neoplastic Stem Cells, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Apoptosis, Drug Resistance, Neoplasm, Protein Kinase Inhibitors, STAT3 Transcription Factor, Mice, Small Molecule Libraries, Metabolome, Transcriptome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Metabolic alterations mediated by STAT3 promotes drug persistence in CML. https://app.cochat.ai/papers/10.1038/s41375-021-01315-0
- The paper
- Patel, S. B., Nemkov, T., Stefanoni, D., Benavides, G. A., Bassal, M. A., Crown, B. L., Matkins, V. R., Camacho, V., Kuznetsova, V., Hoang, A. T., Tenen, D. E., Wolock, S. L., Park, J., Ying, L., Yue, Z., Chen, J. Y., Yang, H., Tenen, D. G., Ferrell, P. B., . . . Welner, R. S. (2021). Metabolic alterations mediated by STAT3 promotes drug persistence in CML. Leukemia. https://doi.org/10.1038/s41375-021-01315-0
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.